Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsByron Jeffers - VP, Treasurer & Head of ...
First American's fourth quarter 2025 results will be discussed in more detail on Thursday, Feb. 12, 2026, at 11 a.m. EST, via teleconference. The toll-free dial-in number is +1-877-407-8293. Callers ...
ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, ...
In 2025, both new and returning member cohort contribution profit performed in line with expectations. Returning member contribution profit remained strong at $200 PMPM year-over-year. New member ...
The drinks CMO tells Tim Healey why modern marketers must “go toe-to-toe with finance,” prove ROI and balance creative ...
Fellow shareholders, Axon completed another record year in pursuit of our mission to protect life. Revenue grew 33% year over year, marking our fourth consecutive year of annual g ...
Asian investors should take a more nuanced approach than either pure complacency or panic selling Read more at The Business Times.
Net bookings totaled $5.6 billion in the fourth quarter and $17.5 billion for fiscal year 2025, representing book-to-bill ratios of 1.3 and 1.0, respectively. As a result, backlog at the end of fiscal ...
What types of animals do veterinarians specializing in exotic species commonly see in practice? S. Emi Knafo, DVM, DACZM, zoological medicine specialist and assistant clinical professor of zoological ...
Merck Animal Health announced today the FDA approved atinvicitinib tablets (NUMELVI; Merck Animal Health), making it the first and only second-generation Janus kinase (JAK) inhibitor indicated for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results